The pharmaceutical companies listed below (the “Companies”) jointly submit this letter in support of the Securities and Exchange Commission’s (the “Commission”) proposed semiannual reporting rule. As public companies, including several with longstanding reporting practices, the Companies are well-positioned to offer perspective on how this proposal would function in practice. Companies: Bristol Myers Squibb Company Eli […]

Source: Harvard Law School Forum on Corporate Governance

Published: 2026-07-18T11:30:01Z